Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAP...

por Mahomed, Sharana, Garrett, Nigel, Potloane, Disebo, Sikazwe, Izukanji T, Capparelli, Edmund, Harkoo, Ishana, Gengiah, Tanuja Narayansamy, Zuma, Nonhlanhla Yende, Osman, Farzana, Mansoor, Leila, Archary, Derseree, Myeni, Nqobile, Radebe, Precious, Samsunder, Natasha, Doria-Rose, Nicole, Carlton, Kevin, Gama, Lucio, Koup, Richard A, Narpala, Sandeep, Serebryannyy, Leonid, Moore, Penny, Williamson, Carolyn, Pozzetto, Bruno, Hankins, Catherine, Morris, Lynn, Karim, Quarraisha Abdool, Abdool Karim, Salim
Publicado 2023